Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. [electronic resource]
Producer: 20090908Description: 303-7 p. digitalISSN:- 1534-6080
- ABO Blood-Group System
- Adult
- Agglutination -- drug effects
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- blood
- Blood Group Incompatibility
- Blood Grouping and Crossmatching
- Catheterization, Peripheral -- adverse effects
- Combined Modality Therapy
- Female
- Graft Rejection -- blood
- Graft Survival -- drug effects
- Hepatic Artery
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Liver Cirrhosis -- blood
- Liver Transplantation
- Living Donors
- Male
- Middle Aged
- Pilot Projects
- Plasma Exchange
- Portal Vein
- Rituximab
- Splenectomy
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.